カテゴリ： Bizwit Research & Consulting, 世界, 医療/バイオ

免疫学のグローバル市場（2022年-2029年）：モノクローナル抗体、免疫抑制剤、融合タンパク質、その他

■ 英語タイトル：Global Immunology Market Size study & Forecast, by Drug Class (Monoclonal Antibody, Immunosuppressants, Fusion Proteins, Others) by Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2022-2029

調査会社Bizwit Research & Consulting社が発行したリサーチレポート（データ管理コード：BZW23MA002）■ 発行会社/調査会社：Bizwit Research & Consulting
■ 商品コード：BZW23MA002
■ 発行日：2023年4月17日
■ 調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
■ 産業分野：医療
■ ページ数：約200
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用、印刷不可）USD4,950 ⇒換算￥732,600見積依頼/購入/質問フォーム
Enterprisewide（同一法人内共有可）USD6,250 ⇒換算￥925,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Bizwit Research & Consulting社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[免疫学のグローバル市場（2022年-2029年）：モノクローナル抗体、免疫抑制剤、融合タンパク質、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Bizwit Research社の本調査資料によると、2021年に979.3億ドルであった世界の免疫学市場規模が、予測期間中（2022年〜2029年）に年平均8.5%で成長すると予想されています。本資料は、免疫学の世界市場にフォーカスし、市場状況や今後の展望についてまとめており、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、薬物クラス別（モノクローナル抗体、免疫抑制剤、融合タンパク質、その他）分析、疾患別（乾癬性関節炎、局面型乾癬、強直性脊椎炎、炎症性腸疾患、その他）分析、流通チャネル別（病院薬局、小売薬局、オンライン薬局）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、その他地域）分析、競争分析、調査プロセスなどを掲載しています。本書は、主要企業として、AbbVie, Inc. 、Janssen Global Services, LLC 、Eli Lilly and Company、Novartis AG 、Pfizer Inc. 、Bristol-Myers Squibb Company 、Merck Sharp & Dohme Corp.、F. Hoffmann-La Roche Ltd. 、Amgen Inc. 、Astellas Pharma Inc.などの情報が含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界の免疫学市場規模：薬物クラス別
- モノクローナル抗体の市場規模
- 免疫抑制剤の市場規模
- 融合タンパク質の市場規模
- その他薬物クラスの市場規模
・世界の免疫学市場規模：疾患別
- 乾癬性関節炎の市場規模
- 局面型乾癬の市場規模
- 強直性脊椎炎の市場規模
- 炎症性腸疾患の市場規模
- その他適応症の市場規模
・世界の免疫学市場規模：流通チャネル別
- 病院薬局チャネルの市場規模
- 小売薬局チャネルの市場規模
- オンライン薬局チャネルの市場規模
・世界の免疫学市場規模：地域別
- 北米の免疫学市場規模
- ヨーロッパの免疫学市場規模
- アジア太平洋の免疫学市場規模
- 中南米の免疫学市場規模
- その他地域の免疫学市場規模
・競争分析
・調査プロセス

Global Immunology Market is valued at approximately USD 97.93 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2022-2029. Immunology is the field of medical and biological research that focuses and studies the immune system. The immune system protects individuals from infection in numerous ways. by enhancing or inhibiting the immune system, immunology medications and substances alter the immunological response. Immunology drugs or agents are used to treat or prevent infections as well as several autoimmune and immunological diseases such type 1 diabetes, rheumatoid arthritis, and psoriatic arthritis. The global market growth is primarily driven by the factors such as a surge in demand for biosimilars, growing awareness about immunological diseases, coupled with the increasing demand for preventive care.

In addition, the rise in incidences of autoimmune disorders is a key factor that is stipulating the market demand in the global market. A study by the National Stem Cell Foundation estimates that at least one of 80 or more autoimmune illnesses affects about 4% of people around the world. For instance, various market participants are focusing on creating and introducing new products to the market as a result of the growing demand for these medications among patients. For instance, Lupin introduced a generic rheumatoid arthritis medication in September 2020. Likewise, As of April 2022, there were approximately 20 pipeline projects from Johnson & Johnson Services, Inc. for a variety of autoimmune indications, including psoriatic arthritis, rheumatoid arthritis, inflammatory bowel disease, and others, and approximately 30 pipeline projects from Sanofi in the immunology segment. Thereby, the increasing prevalence of autoimmune disorders and growing emphasis on introducing its treatments is boosting the market growth. Moreover, the rising introduction of novel therapies, as well as the increasing product approvals by regulatory agencies are presenting various lucrative opportunities over the forecasting years. However, the high cost of treatment and adverse effects associated with the product are hampering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Immunology Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the availability of advanced healthcare infrastructure, along with growing investment on research and development activities. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as rising occurrence of autoimmune conditions, surging demand for preventive care, and increasing drug approvals in the regional market space.

Major market players included in this report are:
AbbVie, Inc.
Janssen Global Services, LLC
Eli Lilly and Company
Novartis AG
Pfizer Inc.
Bristol-Myers Squibb Company
Merck Sharp & Dohme Corp.
F. Hoffmann-La Roche Ltd.
Amgen Inc.
Astellas Pharma Inc.

Recent Developments in the Market:
 In June 2022, Eli Lilly and Company received the U.S. FDA approval for its OLUMIANT- a first-in-disease systemic treatment that is specially developed for adults with severe alopecia areata (AA), an autoimmune disorder.
 In April 2022, AbbVie Inc. received the U.S. FDA approval for its RINVOQ to provide treatment to adult patients with active ankylosing spondylitis.
 In March 2022, Pfizer Inc. announced that the company acquired Arena Pharmaceuticals, a company that primarily focuses on advancing innovative potential therapies to cure several immuno-inflammatory diseases. The objective of this acquisition is to expand Pfizer Inc. product portfolio.

Global Immunology Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Drug Class, Disease Indication, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:
Monoclonal Antibody
Immunosuppressants
Fusion Proteins
Others

By Disease Indication:
Rheumatoid Arthritis
Psoriatic Arthritis
Plaque Psoriasis
Ankylosing Spondylitis
Inflammatory Bowel Disease
Others

By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Immunology Market, by Region, 2019-2029 (USD Billion)
1.2.2. Immunology Market, by Drug Class, 2019-2029 (USD Billion)
1.2.3. Immunology Market, by Disease Indication, 2019-2029 (USD Billion)
1.2.4. Immunology Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Immunology Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Immunology Market Dynamics
3.1. Immunology Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidences of autoimmune disorders
3.1.1.2. Surge in demand for biosimilars
3.1.2. Market Challenges
3.1.2.1. High cost of treatment
3.1.2.2. Adverse effects associated with product
3.1.3. Market Opportunities
3.1.3.1. Rising Introduction of innovative products
3.1.3.2. Increasing product approvals by regulatory agencies
Chapter 4. Global Immunology Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Immunology Market, by Drug Class
6.1. Market Snapshot
6.2. Global Immunology Market by Drug Class, Performance – Potential Analysis
6.3. Global Immunology Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
6.4. Immunology Market, Sub Segment Analysis
6.4.1. Monoclonal Antibody
6.4.2. Immunosuppressants
6.4.3. Fusion Proteins
6.4.4. Others
Chapter 7. Global Immunology Market, by Disease Indication
7.1. Market Snapshot
7.2. Global Immunology Market by Disease Indication, Performance – Potential Analysis
7.3. Global Immunology Market Estimates & Forecasts by Disease Indication 2019-2029 (USD Billion)
7.4. Immunology Market, Sub Segment Analysis
7.4.1. Rheumatoid Arthritis
7.4.2. Psoriatic Arthritis
7.4.3. Plaque Psoriasis
7.4.4. Ankylosing Spondylitis
7.4.5. Inflammatory Bowel Disease
7.4.6. Others
Chapter 8. Global Immunology Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Immunology Market by Distribution Channel, Performance – Potential Analysis
8.3. Global Immunology Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
8.4. Immunology Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Online Pharmacies
Chapter 9. Global Immunology Market, Regional Analysis
9.1. Immunology Market, Regional Market Snapshot
9.2. North America Immunology Market
9.2.1. U.S. Immunology Market
9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
9.2.1.2. Disease Indication breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Immunology Market
9.3. Europe Immunology Market Snapshot
9.3.1. U.K. Immunology Market
9.3.2. Germany Immunology Market
9.3.3. France Immunology Market
9.3.4. Spain Immunology Market
9.3.5. Italy Immunology Market
9.3.6. Rest of Europe Immunology Market
9.4. Asia-Pacific Immunology Market Snapshot
9.4.1. China Immunology Market
9.4.2. India Immunology Market
9.4.3. Japan Immunology Market
9.4.4. Australia Immunology Market
9.4.5. South Korea Immunology Market
9.4.6. Rest of Asia Pacific Immunology Market
9.5. Latin America Immunology Market Snapshot
9.5.1. Brazil Immunology Market
9.5.2. Mexico Immunology Market
9.5.3. Rest of Latin America Immunology Market
9.6. Rest of The World Immunology Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. AbbVie, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Janssen Global Services, LLC
10.2.3. Eli Lilly and Company
10.2.4. Novartis AG
10.2.5. Pfizer Inc.
10.2.6. Bristol-Myers Squibb Company
10.2.7. Merck Sharp & Dohme Corp.
10.2.8. F. Hoffmann-La Roche Ltd.
10.2.9. Amgen Inc.
10.2.10. Astellas Pharma Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

List of Tables
TABLE 1. Global Immunology Market, report scope
TABLE 2. Global Immunology Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Immunology Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
TABLE 4. Global Immunology Market estimates & forecasts by Disease Indication 2019-2029 (USD Billion)
TABLE 5. Global Immunology Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 6. Global Immunology Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Immunology Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Immunology Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Immunology Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Immunology Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Immunology Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Immunology Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Immunology Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Immunology Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Immunology Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Immunology Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Immunology Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Immunology Market
TABLE 71. List of primary sources, used in the study of global Immunology Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 多発性硬化症（MS）治療薬のグローバル市場（2022年-2029年）：免疫調節剤、免疫抑制剤、インターフェロン
  • ベーチェット病のグローバル市場（2022年-2029年）：コルチコステロイド、免疫抑制剤＆免疫調節剤
  • 肝疾患治療のグローバル市場（2022年-2029年）：抗ウイルス薬、免疫抑制剤、ワクチン、免疫グロブリン、副腎皮質ホルモン、標的療法、化学療法
  • タンパク質治療薬のグローバル市場（2023年-2030年）：モノクローナル抗体、インスリン、融合タンパク質、エリスロポエチン、インターフェロン、ヒト成長ホルモン、卵胞刺激ホルモン
  • バイオエンジニアリングタンパク質医薬品のグローバル市場（2022年-2029年）：組換えタンパク質医薬品、ペプチドホルモン、ワクチン、治療用酵素、モノクローナル抗体、サイトカイン、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(BZW23MA002 )"免疫学のグローバル市場（2022年-2029年）：モノクローナル抗体、免疫抑制剤、融合タンパク質、その他" (英文：Global Immunology Market Size study & Forecast, by Drug Class (Monoclonal Antibody, Immunosuppressants, Fusion Proteins, Others) by Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2022-2029)はBizwit Research & Consulting社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。